6-K/A

FORM 6-K AMENDMENT

Company: Arbutus Biopharma Corp
Filed: January 17, 2013
Period of Report: January 17, 2013
Accession Number: 0001193125-13-016117

View Document ↗ View on SEC.gov ↗